ALPS ETF TR - MED BREAKTHGH (SBIO)

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / MED BREAKTHGH
Total 13F shares
596,596
Share change
-143,398
Total reported value
$16,615,003
Put/Call ratio
146%
Price per share
$27.85
Number of holders
25
Value change
-$3,744,751
Number of buys
10
Number of sells
10

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q2 2017

As of 30 Jun 2017, ALPS ETF TR - MED BREAKTHGH (SBIO) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 596,596 shares. The largest 10 holders included UBS Group AG, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, RAYMOND JAMES & ASSOCIATES, Virtu Financial LLC, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CAMBRIDGE TRUST CO, NTV Asset Management LLC, and ROYAL BANK OF CANADA. This page lists 25 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.